
Vitaly Margulis, M.D.
Professor
Endowed Title Paul C. Peters, M.D., Chair in Urology
School Medical School
Department Urology
You have reached the Academic Profile.
For more information on the doctor and patient care, please visit the clinical profile.
View Clinical Profile
Biography
Upon completion of a B.S. degree in biology and biochemistry with highest honors at the University of Texas, and honors medical degree at The University of Texas Southwestern Medical School, I was accepted into a highly competitive urology residency at the University of Texas Southwestern Medical Center in Dallas. During residency training, additional research time was focused on minimally invasive techniques to manage small renal masses, evaluation of a novel approach to perform nephron sparing surgery utilizing radiofrequency ablation, and utilization of tissue micro-array technology to evaluate biomarkers as predictors of bladder cancer outcome. Upon completion of rigorous clinical training in urology, I have entered and completed urologic oncology fellowship at the MD Anderson Cancer Center, where my research focus was on understanding the molecular biology of renal cell carcinogenesis and progression as a model for developing novel diagnostic and therapeutic strategies for this disease. Specifically, our group investigated the role of TGF-beta signal transduction in human renal cell carcinoma with goals of developing targeted therapies. Current scientific endeavors include identification of novel biomarkers in renal cell carcinoma, which could potentially allow for timely diagnosis, staging, prognostication and identification of candidates for adjuvant systemic therapies.
Education
- Medical School
- UT Southwestern Medical School (2001)
- Internship
- UT Southwestern Medical Center (2002), General Surgery
- Residency
- UT Southwestern Medical Center (2006), Urology
- Fellowship
- UT MD Anderson Cancer Center (2009), Urologic Oncology
Research Interest
- Metastatic progression and resistance to targeted therapies
- Molecular biology involved in renal cell cancer tumorigenesis
Publications
Featured Publications
- Magnetic Resonance Imaging - guided In-bore and Magnetic Resonance Imaging-transrectal Ultrasound Fusion Targeted Prostate Biopsies: An Adjusted Comparison of Clinically Significant Prostate Cancer Detection Rate
- Costa D, Goldberg K, de Leon A, Lotan Y, XI Y, Aziz M, Frefeld Y, Margulis V, Raj G, Roehrborn CG, Hornberger B, Desai N, Bagrodia A, Francis F, Pedrosa I, Cadeddu J. 2019
- Stereotactic radiation therapy of renal cancer inferior vena cava tumor thrombus
- Freifeld Y, Margulis V, Woldu S, Timmerman R, Brugarolas J, Hannan R. 2019
- Detection of invasive renal cell carcinoma with targeted molecular imaging
- Margulis V, Hammers H, Sun X, Taneja S, Salzer J. 2019
- Optimal sampling scheme in men with abnormal multiparametric MRI undergoing MRI-TRUS fusion prostate biopsy. Urologic Oncology: Seminars and Original Investigations
- Freifeld Y, Xi Y, Passoni N, Woldu S, Hornberger B, Goldberg K, Bagrodia A, Raj G, Margulis V, Cadeddu J, Lotan Y, Francis F, Pedrosa I, Roehrborn CG, Costa D. 2018
- Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Carcinoma Extracranial Metastases.
- Wang CJ, Christie A, Lin MH, Jung M, Weix D, Huelsmann L, Kuhn K, Meyer J, Desai N, Kim DWN, Pedrosa I, Margulis V, Cadeddu J, Sagalowsky A, Gahan J, Laine A, Xie XJ, Choy H, Brugarolas J, Timmerman R, Hannan R Int. J. Radiat. Oncol. Biol. Phys. 2017 May 98 1 91-100
- A Multi-Institutional Comparison of Clinicopathological Characteristics and Oncologic Outcomes of Upper Tract Urothelial Carcinoma in China and the United States
- Singla N, Fang D, Su X, Bao Z, Cao Z, Jafri SM, Xiong G, Zhang L, Hutchinson R, Sagalowsky AI, Lotan Y, Li X, Zhou L, Raman JD, Margulis V 2017
- Impact of Hospital caseVolume on Testicular Cancer Outcomes and Practice Patterns
- Woldu SL, Matulay JT, Clinton TN, Singla N, Krabbe LM, Hutchinson RC, Sagalowsky A, Lotan Y, Margulis V, Bagrodia A. 2017
- Differences at Presentation and Treatment of Testicular Cancer in Hispanic Men: Institutional and National Hospital-based Analyses
- Woldu Sl, Aydin AM, Rao AV, Hutchinson RC, Singla N, Clinton TN, Krabbe LM, Passoni NM, Raj GV, Miller DS, Amatruda JF, Sagalowsky A, Lotan Y, Arriaga Y, Margulis V, Bagrodia A. 2017
- Oncology: Adrenal/Renal/Upper Tract/Bladder Prognostic Value of PD-1 and PD-L1 Expression in Patients with High Grade Upper Tract Urothelial Carcinoma
- Krabbe LM, Heitzplatz B, Presuss S, Hutchinson RC, Woldu SL, Singla N, Boegemann M, Wood CG, Karam JA, Weizer AZ, Raman JD, Remzi M, Rioux-Leclercg N, Haitel A, Rapoport LM, Glybochko PV, Roscigno M, Bolenz C, Bensaleh K, Sagalowsky AI, Shariat SF, Lotan Y, Xylinas E, Margulis V. 2017
- Androgen receptor expression is associated with adverse pathological features in ureteral but not in pelvicalyceal urothelial carcinomas of the upper urinary tract.
- Wirth GJ, Haitel A, Moschini M, Soria F, Klatte T, Hassler MR, Bensalah K, Briganti A, Karam JA, Lotan Y, Margulis V, Raman JD, Remzi M, Rioux-Leclercq N, Robinson BD, RouprĂȘt M, Wood CG, Shariat SF World J Urol 2016 Oct
Honors & Awards
- Merit Award
American Society of Clinical Oncology (2008) - National Institute of Health Clinical Research Scientist LRP Award
NIH (2007) - American Urological Association Foundation Research Scholar Award
AFUD/AUA (2006) - Ruth L. Kirschstein National Research Service Award
University of Texas MD Anderson Cancer Center (2006) - Alpha Omega Alpha
UT Southwestern Medical School (2001)
Professional Associations/Affiliations
- American Association for Cancer Research
- American College of Surgeons
- American Medical Association
- American Society of Clinical Oncology
- American Urological Association
- Dallas County Medical Society
- Endourologic Society
- Harris County Medical Society
- Society of Urologic Oncology
- Texas Medical Association